Selected ventures to receive grants and structured intellectual property support to strengthen protection and management of healthcare innovations
Proprietary technologies in LNP-based delivery of mRNA and DNA vectors to advance T-CURX innovative in vivo CAR-T assets into clinical trials one year earlier
The designation marks the first Breakthrough Therapy recognition for calderasib and is backed by positive results from the Phase 1 KANDLELIT-001 clinical trial
The finance leader and investment banking veteran to steer global financial strategy, investor relations, and growth initiatives
India already has talent, digital infrastructure, entrepreneurial energy, clinical expertise, and policy momentum. The next phase demands coordinated execution and building institutions that can hold the ecosystem together over time
Combined platform with 55+ centres aims to expand integrated maternity, fertility, neonatal and paediatric care across India
Combined footprint expands to 420 hearing care centres across India
The global pharmaceutical company has been featured in both the DJBIC World Index and the DJBIC Emerging Markets Index
30,000 sq. ft. multispeciality facility aims to deliver integrated care for women across every life stage
Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities
Subscribe To Our Newsletter & Stay Updated
